Inpharamo will Facilitate Clinerion into Mexican Clinical Research Market


Applied Clinical Trials

Inpharamo, a subsidiary of Semicrol, has signed a collaboration agreement to support the entry of the Swiss company, Clinerion. The partnership is dedicated to optimizing the identification of patients who are candidates for participation in clinical trials in Mexico.

For more information, click here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.